Friday, July 10, 2026

pharma · Ependymoma, Medulloblastoma · chronically occluded coronary artery

Ishita Pharma -

News and analysis for Ishita Pharma - on NovaPharmaNews — regulatory, clinical, and market coverage.

Mumbai, IN HQ
3 Employees
EMA registrant Type
Company details
Status
Public
HQ
Mumbai, IN
Employees
3
Programs
8
Drugs
19
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Ishita Pharma - — regulatory, clinical, and market coverage.

News and analysis for Ishita Pharma - on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Ishita Pharma - yet.

Back to company overview →